CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,478 enrolled
Drug / intervention
Respiratory nasal swabprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02979626
NCT02979626N/ACompleted
CompareCT.gov

Evaluation of Moderate to Severe Influenza Disease in Children 6 Months to 8 Years in Colorado

University of Colorado, Denver·observational·Posted Dec 1, 2016·Updated Feb 4, 2021

In Brief

An observational study evaluating Respiratory nasal swab for Influenza and 5 related conditions. Completed, enrolled 1,478 participants across 2 sites.

Detailed Summary

The purpose of this study was to determine whether moderate-severe endpoints (including high fever, lower respiratory tract disease, acute otitis media, or serious extra-pulmonary complications) were predictive of hospitalization, intensive care admission, antibiotic use and other complications in children under 8 years of age.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsInfluenza, Otitis Media, Lower Resp Tract Infection, Encephalitic Infection, Myositis Viral, Fever
CountriesUnited States
CollaboratorsGlaxoSmithKline

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedDec 1, 2016
Enrollment StartJan 30, 2017
Primary CompletionMay 4, 2018
Study CompletionMay 5, 2018
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 9.6 years ago

Interventions

Respiratory nasal swabprocedure

Nasal swabs will be obtained for testing by the study nurses. If a respiratory sample has already been collected as part of routine clinical care, this will replace the study collection, and no additional testing will be required.